Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 9551 - 9560 of 13501 results

First page
Previous page
Next page
Next page

SINISTRIN

Y83V3FE29B

Status:

Investigational

Source:

NCT02109029: Phase 1 Interventional Completed Diabetes Mellitus, Type 1

(2014)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT02109029

Class:

POLYMER

CARBOXYMETHYLCELLULOSE SODIUM (1.3 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 3800 MPA.S AT 1%)

97W605BIK0

Status:

Investigational

Source:

JAN:CARMELLOSE SODIUM [JAN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/97W605BIK0

Class:

POLYMER

FIRTECAN PEGOL

WC4978T687

Status:

Investigational

Source:

NCT00931840: Phase 2 Interventional Unknown status Metastatic Colorectal Cancer

(2009)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00931840

Class:

POLYMER

PEG-6 Laurate

N77L7I984W

Status:

Investigational

Source:

NCT00348764: Phase 3 Interventional Completed Venous Insufficiency

(2004)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT00348764

Class:

POLYMER

Zertomibgene Cazparvovec

64SQ6WC9ET

Status:

Investigational

Source:

INN:zertomibgene cazparvovec [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/64SQ6WC9ET

Class:

STRUCTURALLY DIVERSE

Onzemipgene Parvec

WU56BNE7AU

Status:

Investigational

Source:

INN:onzemipgene parvec [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/WU56BNE7AU

Class:

STRUCTURALLY DIVERSE

Neldaleucel

78SU4N7MVG

Status:

Investigational

Source:

INN:13215

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/78SU4N7MVG

Class:

STRUCTURALLY DIVERSE

Linoserpaturev

KCT7UM8G55

Status:

Investigational

Source:

INN:linoserpaturev [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/KCT7UM8G55

Class:

STRUCTURALLY DIVERSE

Pritebegene Zepadenovec

2FFJ8WJ6EM

Status:

Investigational

Source:

INN:pritebegene zepadenovec [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/2FFJ8WJ6EM

Class:

STRUCTURALLY DIVERSE

Soficabtagene Geleucel

Z75Y8V4FFA

Status:

Investigational

Source:

INN:soficabtagene geleucel [INN]

Source URL:

https://ginas.ncats.nih.gov/ginas/app/substance/Z75Y8V4FFA

Class:

STRUCTURALLY DIVERSE

Structure of SINISTRIN

Polymer

Structure of CARBOXYMETHYLCELLULOSE SODIUM (1.3 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 3800 MPA.S AT 1%)

Polymer

CARBOXYMETHYLCELLULOSE SODIUM (1.3 CARBOXYMETHYL SUBSTITUTION PER SACCHARIDE; 3800 MPA.S AT 1%)

Structure of FIRTECAN PEGOL

Polymer

Structure of PEG-6 Laurate

Polymer

Structurally Diverse

Zertomibgene Cazparvovec

Structurally Diverse

Onzemipgene Parvec

Structurally Diverse

Neldaleucel

Structurally Diverse

Structurally Diverse

Pritebegene Zepadenovec

Structurally Diverse

Soficabtagene Geleucel

Showing 9551 - 9560 of 13501 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1